CD86 and rheumatoid arthritis: In conclusion, based on our retrospective analyses, the CTLA-4 rs231775 gene polymorphisms decreased the risk of RA, whereas the CTLA-4 rs16840252 and CD86 rs17281995 gene polymorphisms were not related to RA risk.